Simran
Simran is pursuing a combined MD/PhD in the Harvard-MIT MD program and Immunology PhD program. Previously, she was a research technician at Fred Hutch, where she helped design novel protein-based cancer therapeutics and a SARS-CoV-2 vaccine.
Sirus
Sirus holds a BS in Biochemistry & Cell Biology (Rice) and an MD (Baylor College of Medicine). He is completing his Internal Medicine training at Mass General Hospital and serves as a Clinical Fellow at Harvard Medical School.
Michael
Mike is a Nuclear Science and Engineering PhD student at at MIT. He graduated from Missouri S&T with a major in Nuclear Engineering, and a minor in Mathematics & Material Sciences.